Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
159.1 USD | -1.62% | -4.88% | +2.68% |
30/04 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
29/04 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.68% | 286B | |
+31.03% | 699B | |
+25.07% | 571B | |
-4.70% | 364B | |
+18.13% | 326B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-4.44% | 154B | |
-3.97% | 149B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Truist Adjusts Price Target on AbbVie to $180 From $160, Maintains Buy Rating